rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-11-24
|
pubmed:abstractText |
Diagnosis and follow-up of bone metastasis (BMet) in non-small cell lung cancer (NSCLC) patients usually rely on symptoms and image studies. A serum marker of bone resorption may improve the quality of treatment in such patients. Tartrate-resistant acid phosphatase 5b (TRACP5b) is a specific marker for osteoclasts and we proposed it can be used as a marker of BMet in NSCLC patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1873-3492
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
412
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
181-5
|
pubmed:meshHeading |
pubmed-meshheading:20932965-Acid Phosphatase,
pubmed-meshheading:20932965-Adult,
pubmed-meshheading:20932965-Aged,
pubmed-meshheading:20932965-Aged, 80 and over,
pubmed-meshheading:20932965-Bone Neoplasms,
pubmed-meshheading:20932965-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20932965-Case-Control Studies,
pubmed-meshheading:20932965-Female,
pubmed-meshheading:20932965-Follow-Up Studies,
pubmed-meshheading:20932965-Humans,
pubmed-meshheading:20932965-Isoenzymes,
pubmed-meshheading:20932965-Lung Neoplasms,
pubmed-meshheading:20932965-Male,
pubmed-meshheading:20932965-Middle Aged,
pubmed-meshheading:20932965-ROC Curve,
pubmed-meshheading:20932965-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
|
pubmed:affiliation |
Division of Hematology and Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|